Anemia in pregnancy

Anemia is a condition in which blood has a lower-than-normal amount of red blood cells or hemoglobin.[1] Anemia in pregnancy is a decrease in the total red blood cells (RBCs) or hemoglobin in the blood during pregnancy. Anemia is an extremely common condition in pregnancy world-wide, conferring a number of health risks to mother and child.[2] While anemia in pregnancy may be pathologic, in normal pregnancies, the increase in RBC mass is smaller than the increase in plasma volume, leading to a mild decrease in hemoglobin concentration referred to as physiologic (or dilutional) anemia.[3] Maternal signs and symptoms are usually non-specific, but can include: fatigue, pallor, dyspnea, palpitations, and dizziness.[4] There are numerous well-known maternal consequences of anemia including: maternal cardiovascular strain, reduced physical and mental performance, reduced peripartum blood reserves, increased risk for peripartum blood product transfusion, and increased risk for maternal mortality.[5]

Signs and symptoms[edit]

Common symptoms are headache, fatigue, lethargy, tachycardia, tachypnea, paresthesia, pallor, glossitis and cheilitis.[6][7] Severe symptoms include congestive heart failure, placenta previa, abruptio placenta, and operative delivery.[6][8]

Causes[edit]

In the simplest of terms, anemia results from impaired production of red blood cells, increased destruction of red blood cells or blood loss. Anemia can be congenital (i.e. conditions such as sickle cell anemia and thalassemia) or acquired (i.e., conditions such as iron-deficiency anemia or anemia as a result of an infection). The causes of anemia during pregnancy can be subdivided into two main categories; physiologic and non-physiologic causes.[citation needed]

Physiologic Causes

Dilutional anemia: There is an increase in overall blood volume during pregnancy, and even though there is an increase in overall red blood cell mass, the increase in the other parts of the blood like plasma decrease the overall percentage of red blood cells in

circulation.[9]

Non-physiologic Causes[7]

Iron deficiency anemia: this can occur from the increased production of red blood cells, which requires a lot of iron and also from inadequate intake of iron, which increase in pregnancy.

Hemoglobinopathies: Thalassemia and sickle cell disease

Dietary deficiencies: Folate deficiency and vitamin B12 deficiency are common causes of anemia in pregnancy. Folate deficiency occurs due to diets low in leafy green vegetables, and animal sources of protein.[10] B12 deficiency tends to be more common in individuals with Crohn's disease or gastrectomies.[11]

Cell membrane disorders: Hereditary spherocytosis

Autoimmune causes: lead to the hemolysis of red blood cells (Ex: autoimmune hemolytic anemia).[12]

Hypothyroidism and chronic kidney disease[13][14]

Parasitic infestations: some examples are hookworm or Plasmodium species

Bacterial or viral infections

Iron deficiency is the most common cause of anemia in the pregnant woman. During pregnancy, the average total iron requirement is about 1200 mg per day for a 55 kg woman. This iron is used for the increase in red cell mass, placental needs and fetal growth. About 40% of women start their pregnancy with low to absent iron stores and up to 90% have iron stores insufficient to meet the increased iron requirements during pregnancy and the postpartum period.[15]

The majority of women presenting with postpartum anemia have pre-delivery iron deficiency anemia or iron deficiency anemia combined with acute blood loss during delivery.[16]

Adverse outcomes[edit]

Maternal outcomes[edit]

Studies have suggested that severe maternal morbidity (SMM) is increased approximately twofold in antepartum maternal anemia. SMM is defined by maternal death, eclampsia, transfusion, hysterectomy, or intensive care unit admission at delivery. Additional complications may include postpartum haemorrhage, preeclampsia, cesarean delivery, and infections.[17]

Fetal outcomes[edit]

Iron deficiency during pregnancy is linked to a number of harmful effects on the fetus such as intrauterine growth restriction, death in utero, infection, preterm delivery and neurodevelopmental damage, which may be irreversible.[18][19][20]

Diagnosis[edit]

The most useful test with which to render a diagnosis of anemia is a low RBC count, however hemoglobin and hematocrit values are most commonly used in making the initial diagnosis of anemia. Testing involved in diagnosing anemia in pregnant women must be tailored to each individual patient. Suggested tests include: hemoglobin and hematocrit (ratio of red blood cells to the total blood volume), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), erythrocyte count (number of red blood cells in the blood), red cell distribution width (RDW), reticulocyte count, and a peripheral smear to assess red blood cell morphology. If iron deficiency is suspected, additional tests such as: serum iron, total iron-binding capacity (TIBC), transferrin saturation, and plasma or serum ferritin may be warranted. It is important to note that references ranges for these values are often not the same for pregnant women. Additionally, laboratory values for pregnancy often change throughout the duration of a woman's gestation. For example, the reference values for what level of hemoglobin is considered anemic varies in each trimester of pregnancy.[21][9]

- First trimester hemoglobin < 11 g/dL

- Second trimester hemoglobin < 10.5 g/dL

- Third trimester hemoglobin < 11 g/dL

- Postpartum hemoglobin < 10 g/dL

Listed below are normal ranges for important lab values in the diagnosis of anemia. Keep in mind that these ranges might change based on each patient's stage in pregnancy:[7]

- Hemoglobin: Men (13.6-16.9), women (11.9-14.8)

- Hematocrit: Men (40-50%), women (35-43%)

- MCV: 82.5 - 98

- Reticulocyte count: Men (16-130X10^3/microL or X10^9), Women (16-98/microL or X10^9)

Differential using MCV

MCV can be a great measure for differentiating between different forms of anemia. MCV measures the average size of your red blood cells. There are three cut off measurements for MCV. If the MCV is < 80fL it is considered microcytic. If the MCV is from 80 to 100 fL then it is considered a normocytic anemia. If the MCV is > 100 fL it is considered a macrocytic anemia. Some causes of anemia can be characterized by different ranges of MCV depending upon the severity disease. Here are common causes of anemia organized by MCV.[22]

MCV < 80 fL

- Iron deficiency

- Thalassemia

- Anemia of chronic disease or anemia of inflammation

MCV 80 - 100 fL

- Iron deficiency

- Infection

- Hypothyroidism

- Liver disease or alcohol use

- Drug-induced

- Hemolysis

- Vitamin B12 or folate deficiency

MCV > 100 fL

- Vitamin B12 or folate deficiency

- Drug induced

- Liver disease or alcohol use

- Hypothyroidism

- Myelodysplastic Syndromes

Pregnancy[edit]

Pregnant women need almost twice as much iron as women who are not pregnant do. Not getting enough iron during pregnancy raises risk of premature birth or a low-birth-weight baby.[23] Hormonal changes in the pregnant woman result in an increase in circulating blood volume to 100 mL/kg with a total blood volume of approximately 6000–7000 mL. While red cell mass increases by 15–20% during pregnancy, plasma volume increases by 40%.[24] Hemoglobin levels less than 11 g/dL during the first trimester, less than 10.5 g/dL during the second and third trimesters and less than 10 mg/dL in the postpartum period are considered anemic.[25]

Prevention[edit]

Anemia is a very common complication of pregnancy. A mild form of anemia can be a result of dilution of blood. There is a relatively larger increase in blood plasma compared to total red cell mass in all pregnancies, which results in dilution of the blood and causes physiologic anemia . These changes take place to ensure adequate amount of blood is supplied to the fetus and prepares body for expected blood loss at the time of delivery.[26]

More severe forms of anemia can be a due to iron deficiency, vitamin deficiency, or other causes.[citation needed]

Prevention of iron deficiency anemia[edit]

Iron deficiency is the most common cause of non-physiologic anemia. Iron deficiency anemia can be prevented with supplemental oral iron 27–30 mg daily.[27] This dose typically corresponds to the amount of iron found in iron-containing prenatal vitamins. Consult with your medical provider to determine whether additional supplements are needed. Complete routine labs during pregnancy for early detection of iron deficiency anemia.[27]

Iron deficiency anemia can also be prevented by eating iron-rich foods. This includes dark green leafy vegetables, eggs, meat, fish, dried beans, and fortified grains.[28]

Prevention of other causes of anemia[edit]

This may be only applicable to select individuals.

Vitamin B12: Women who consume strictly vegan diets are advised to take Vitamin B12 supplements; this helps prevent anemia due to low Vitamin B12 levels.[29]

Folic Acid: Folic acid supplement recommended for women with history of documented folate deficiency. Folic acid supplementation also recommended for prevention of neural tube defects in the fetus.[29]

Treatment[edit]

For treatment of iron deficiency anemia in pregnant women, iron supplementation at doses higher than prenatal supplements is recommended. The standard doses of oral iron ranges from 40 mg to 200 mg elemental iron daily.[30] Consult with your medical provider to determine the exact dose needed for your condition, higher than needed doses of iron supplements may sometimes lead to more adverse effects.[21]

Iron supplements are easy to take, however adverse effects in some cases may include gastrointestinal side effects, nausea, diarrhea, and/or constipation. In cases when oral iron supplement is not tolerable, other options include longer intervals between each oral dose, liquid iron supplements, or intravenous iron.[21] Intravenous iron may also be used in cases of severe iron deficiency anemia during second and third trimesters of pregnancy.[31]

Anemias due to other deficiencies such as folic acid or vitamin B12 can also be treated with supplementation as well; dose may vary based on level of deficiency.[32]

Other forms of anemias, such as inherited or acquired anemias prior to pregnancy, will require continuous management during pregnancy as well.[29]

Treatment should target the underlying disease or condition affecting the patient.

  • The majority of obstetric anemia cases can be treated based on their etiology if diagnosed in time. Oral iron supplementation is the gold standard for the treatment of iron deficiency anemia and intravenous iron can be used when oral iron is not effective or tolerated from the second trimester of pregnancy onwards.[33]
  • Treatment of postpartum hemorrhage is multifactorial and includes medical management, surgical management along with blood product support.[34][35]

Epidemiology[edit]

According to the WHO estimation, the global prevalence of anemia during pregnancy is over 40%, and the prevalence of anemia during pregnancy in North America is 6%.[36] Prevalence of anemia in pregnancy is higher in developing countries compared to developed countries. 56% of pregnant women from low and middle income countries were reported to have anemia.[37]

Guidelines[edit]

  1. Pavord, S; Myers, B; Robinson, S; Allard, S; Strong, J; Oppenheimer, C (Mar 2012). "UK guidelines on the management of iron deficiency in pregnancy". Br J Haematol. 156 (5): 588–600. doi:10.1111/j.1365-2141.2011.09012.x. PMID 2251200. S2CID 12588512.
  2. Markova, V; Norgaard, A; Jorgensen, KJ; Langhoff-Roos, J (2015). "Treatment for women with postpartum iron deficiency anaemia". Cochrane Database Syst. Rev. 2015 (8): CD010861. doi:10.1002/14651858.CD010861.pub2. PMC 8741208. PMID 26270434.
  3. Peña-Rosas, JP; De-Regil, LM; Garcia-Casal, MN; Dowswell, T (22 July 2015). "Daily oral iron supplementation during pregnancy". The Cochrane Database of Systematic Reviews. 2015 (7): CD004736. doi:10.1002/14651858.CD004736.pub5. PMC 4233117. PMID 26198451.
  4. Dahlke, JD; Mendez-Figueroa, H; Maggio, L; Hauspurg, AK; Sperling, JD; Chauhan, SP; Rouse, DJ (2015). "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines". Am J Obstet Gynecol. 213 (1): 761–10. doi:10.1016/j.ajog.2015.02.023. PMID 25731692.
  5. Shaylor, R; Weiniger, CF; Austin, N; Tzabazis, A; Shander, A; Goodnough, LT; Butwick, AJ (2017). "National and international guidelines for patient blood management in obstetrics: a qualitative review". Anesth Analg. 124 (1): 216–32. doi:10.1213/ANE.0000000000001473. PMC 5161642. PMID 27557476.
  6. Tunçalp, Ő; Souza, JP; Gűlmezoglu, M (Dec 2013). "New WHO recommendations on prevention and treatment of postpartum hemorrhage". Int J Gynaecol Obstet. 123 (3): 254–6. doi:10.1016/j.ijgo.2013.06.024. PMID 24054054. S2CID 40664131.

References[edit]

  1. ^ "Anemia | NHLBI, NIH". www.nhlbi.nih.gov. Retrieved 2020-10-29.
  2. ^ Pavord, Sue; Myers, Bethan; Robinson, Susan; Allard, Shubha; Strong, Jane; Oppenheimer, Christina; British Committee for Standards in Haematology (March 2012). "UK guidelines on the management of iron deficiency in pregnancy". British Journal of Haematology. 156 (5): 588–600. doi:10.1111/j.1365-2141.2011.09012.x. ISSN 1365-2141. PMID 22512001. S2CID 12588512.
  3. ^ American College of Obstetricians Gynecologists' Committee on Practice Bulletins—Obstetrics (August 2021). "Anemia in Pregnancy: ACOG Practice Bulletin, Number 233". Obstetrics & Gynecology. 138 (2): e55–e64. doi:10.1097/AOG.0000000000004477. ISSN 0029-7844. PMID 34293770. S2CID 236198933.
  4. ^ "Home | National Heart, Lung, and Blood Institute (NHLBI)". www.nhlbi.nih.gov. Retrieved 2018-07-25.
  5. ^ Breymann, Christian (October 2015). "Iron Deficiency Anemia in Pregnancy". Seminars in Hematology. 52 (4): 339–347. doi:10.1053/j.seminhematol.2015.07.003. ISSN 1532-8686. PMID 26404445.
  6. ^ a b Sifakis, S.; Pharmakides, G. (2000). "Anemia in Pregnancy". Annals of the New York Academy of Sciences. 900 (1): 125–136. Bibcode:2000NYASA.900..125S. doi:10.1111/j.1749-6632.2000.tb06223.x. ISSN 1749-6632. PMID 10818399. S2CID 6740558.
  7. ^ a b c "UpToDate". www.uptodate.com. Retrieved 2021-09-20.
  8. ^ Flessa, H. C. (December 1974). "Hemorrhagic disorders and pregnancy". Clinical Obstetrics and Gynecology. 17 (4): 236–249. doi:10.1097/00003081-197412000-00015. ISSN 0009-9201. PMID 4615860.
  9. ^ a b American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics (2021-08-01). "Anemia in Pregnancy: ACOG Practice Bulletin, Number 233". Obstetrics and Gynecology. 138 (2): e55–e64. doi:10.1097/AOG.0000000000004477. ISSN 1873-233X. PMID 34293770. S2CID 236198933.
  10. ^ Campbell, B. A. (September 1995). "Megaloblastic anemia in pregnancy". Clinical Obstetrics and Gynecology. 38 (3): 455–462. doi:10.1097/00003081-199509000-00005. ISSN 0009-9201. PMID 8612357.
  11. ^ Parrott, Julie; Frank, Laura; Rabena, Rebecca; Craggs-Dino, Lillian; Isom, Kellene A.; Greiman, Laura (May 2017). "American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients". Surgery for Obesity and Related Diseases. 13 (5): 727–741. doi:10.1016/j.soard.2016.12.018. ISSN 1878-7533. PMID 28392254.
  12. ^ "Autoimmune hemolytic anemia | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2021-09-11.
  13. ^ Green, S. T.; Ng, J. P. (1986). "Hypothyroidism and anaemia". Biomedicine & Pharmacotherapy. 40 (9): 326–331. ISSN 0753-3322. PMID 3828479.
  14. ^ "Anemia in Chronic Kidney Disease | NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 2021-09-11.
  15. ^ Garzon, Simone; Cacciato, Patrizia Maria; Certelli, Camilla; Salvaggio, Calogero; Magliarditi, Maria; Rizzo, Gianluca (2020-09-15). "Iron Deficiency Anemia in Pregnancy: Novel Approaches for an Old Problem". Oman Medical Journal. 35 (5): e166. doi:10.5001/omj.2020.108. PMC 7477519. PMID 32953141.
  16. ^ Mremi, Alex; Rwenyagila, Doris; Mlay, Joseph (2022-02-03). Brownie, Sharon Mary (ed.). "Prevalence of post-partum anemia and associated factors among women attending public primary health care facilities: An institutional based cross-sectional study". PLOS ONE. 17 (2): e0263501. Bibcode:2022PLoSO..1763501M. doi:10.1371/journal.pone.0263501. ISSN 1932-6203. PMC 8812965. PMID 35113955.
  17. ^ Harrison, Rachel K.; Lauhon, Samantha R.; Colvin, Zachary A.; McIntosh, Jennifer J. (September 2021). "Maternal anemia and severe maternal morbidity in a US cohort". American Journal of Obstetrics & Gynecology MFM. 3 (5): 100395. doi:10.1016/j.ajogmf.2021.100395. PMC 8435012. PMID 33992832.
  18. ^ Geng, Fengji; Mai, Xiaoqin; Zhan, Jianying; Xu, Lin; Zhao, Zhengyan; Georgieff, Michael; Shao, Jie; Lozoff, Betsy (December 2015). "Impact of Fetal-Neonatal Iron Deficiency on Recognition Memory at 2 Months of Age". The Journal of Pediatrics. 167 (6): 1226–1232. doi:10.1016/j.jpeds.2015.08.035. ISSN 1097-6833. PMC 4662910. PMID 26382625.
  19. ^ Beard, John L. (December 2008). "Why iron deficiency is important in infant development". The Journal of Nutrition. 138 (12): 2534–2536. doi:10.1093/jn/138.12.2534. ISSN 1541-6100. PMC 3415871. PMID 19022985.
  20. ^ Lozoff, Betsy; Beard, John; Connor, James; Barbara, Felt; Georgieff, Michael; Schallert, Timothy (May 2006). "Long-lasting neural and behavioral effects of iron deficiency in infancy". Nutrition Reviews. 64 (5 Pt 2): S34–43, discussion S72–91. doi:10.1301/nr.2006.may.S34-S43 (inactive 2024-02-10). ISSN 0029-6643. PMC 1540447. PMID 16770951.{{cite journal}}: CS1 maint: DOI inactive as of February 2024 (link)
  21. ^ a b c Pavord, Sue; Daru, Jan; Prasannan, Nita; Robinson, Susan; Stanworth, Simon; Girling, Joanna; BSH Committee (March 2020). "UK guidelines on the management of iron deficiency in pregnancy". British Journal of Haematology. 188 (6): 819–830. doi:10.1111/bjh.16221. ISSN 1365-2141. PMID 31578718. S2CID 203652784.
  22. ^ "UpToDate". www.uptodate.com. Retrieved 2021-09-13.
  23. ^ "Iron-deficiency anemia". womenshealth.gov. 2017-02-17. Retrieved 2020-10-29.
  24. ^ Jansen, A. J. G.; van Rhenen, D. J.; Steegers, E. a. P.; Duvekot, J. J. (October 2005). "Postpartum hemorrhage and transfusion of blood and blood components". Obstetrical & Gynecological Survey. 60 (10): 663–671. doi:10.1097/01.ogx.0000180909.31293.cf. ISSN 0029-7828. PMID 16186783. S2CID 1910601.
  25. ^ Roy, N. B. A.; Pavord, S. (April 2018). "The management of anaemia and haematinic deficiencies in pregnancy and post-partum". Transfusion Medicine (Oxford, England). 28 (2): 107–116. doi:10.1111/tme.12532. ISSN 1365-3148. PMID 29744977. S2CID 13665022.
  26. ^ Sifakis, S.; Pharmakides, G. (2006-01-25). "Anemia in Pregnancy". Annals of the New York Academy of Sciences. 900 (1): 125–136. Bibcode:2000NYASA.900..125S. doi:10.1111/j.1749-6632.2000.tb06223.x. PMID 10818399. S2CID 6740558.
  27. ^ a b "Recommendations to Prevent and Control Iron Deficiency in the United States". www.cdc.gov. Retrieved 2021-09-11.
  28. ^ "Anemia and Pregnancy". www.hematology.org. Retrieved 2021-09-20.
  29. ^ a b c Achebe, Maureen M.; Gafter-Gvili, Anat (2017-02-23). "How I treat anemia in pregnancy: iron, cobalamin, and folate". Blood. 129 (8): 940–949. doi:10.1182/blood-2016-08-672246. ISSN 1528-0020. PMID 28034892.
  30. ^ "Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention". MMWR. Recommendations and Reports. 47 (RR-3): 1–29. 1998-04-03. ISSN 1057-5987. PMID 9563847.
  31. ^ Juul, Sandra E.; Derman, Richard J.; Auerbach, Michael (2019). "Perinatal Iron Deficiency: Implications for Mothers and Infants". Neonatology. 115 (3): 269–274. doi:10.1159/000495978. ISSN 1661-7819. PMID 30759449.
  32. ^ Ankar, Alex; Kumar, Anil (2023), "Vitamin B12 Deficiency", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722952, retrieved 2023-10-12
  33. ^ Markova, Veronika; Norgaard, Astrid; Jørgensen, Karsten Juhl; Langhoff-Roos, Jens (2015-08-13). "Treatment for women with postpartum iron deficiency anaemia". The Cochrane Database of Systematic Reviews. 2015 (8): CD010861. doi:10.1002/14651858.CD010861.pub2. ISSN 1469-493X. PMC 8741208. PMID 26270434.
  34. ^ Dahlke, Joshua D.; Mendez-Figueroa, Hector; Maggio, Lindsay; Hauspurg, Alisse K.; Sperling, Jeffrey D.; Chauhan, Suneet P.; Rouse, Dwight J. (July 2015). "Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines". American Journal of Obstetrics and Gynecology. 213 (1): 76.e1–10. doi:10.1016/j.ajog.2015.02.023. ISSN 1097-6868. PMID 25731692.
  35. ^ Shaylor, Ruth; Weiniger, Carolyn F.; Austin, Naola; Tzabazis, Alexander; Shander, Aryeh; Goodnough, Lawrence T.; Butwick, Alexander J. (January 2017). "National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review". Anesthesia and Analgesia. 124 (1): 216–232. doi:10.1213/ANE.0000000000001473. ISSN 1526-7598. PMC 5161642. PMID 27557476.
  36. ^ "Preconception care to reduce maternal and childhood mortality and morbidity". www.who.int. Retrieved 2021-09-11.
  37. ^ Stephen, Grace; Mgongo, Melina; Hussein Hashim, Tamara; Katanga, Johnson; Stray-Pedersen, Babill; Msuya, Sia Emmanueli (2018-05-02). "Anaemia in Pregnancy: Prevalence, Risk Factors, and Adverse Perinatal Outcomes in Northern Tanzania". Anemia. 2018: 1–9. doi:10.1155/2018/1846280. PMC 5954959. PMID 29854446.